These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 62398)

  • 41. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
    Almogren A
    Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
    Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
    J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies.
    Araujo FG; Barnett EV; Gentry LO; Remington JS
    Appl Microbiol; 1971 Sep; 22(3):270-5. PubMed ID: 4940868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.
    Rubin RL; Teodorescu M; Beutner EH; Plunkett RW
    Lupus; 2004; 13(4):249-56. PubMed ID: 15176661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The evaluation of cellular immune function in elderly patients with systemic lupus erythematosus.
    Men K; Chen Y; Zhang J; Wei D
    Korean J Intern Med; 2019 Jul; 34(4):932-937. PubMed ID: 29172398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antinuclear antibodies in pleural fluid.
    Khare V; Baethge B; Lang S; Wolf RE; Campbell GD
    Chest; 1994 Sep; 106(3):866-71. PubMed ID: 8082370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tissue specificity of antinuclear antibodies in scleroderma.
    Błaszczyk M; Beutner EH; Rogoziński T; Rzesa G; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski TP
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):761-4. PubMed ID: 107922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
    Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
    Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antinuclear antibodies (ANA) and complement fixing ANA in systemic connective tissue diseases.
    Beutner EH; Binder WL; Fang YV; Plunkett RW; Rubin RL
    Immunol Invest; 1998; 27(1-2):97-104. PubMed ID: 9561921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders: a retrospective study.
    Perilloux BC; Shetty AK; Leiva LE; Gedalia A
    Clin Rheumatol; 2000; 19(3):200-3. PubMed ID: 10870654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and clinical significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis.
    Clotet B; Guardia J; Pigrau C; Lience E; Murcia C; Pujol R; Bacardí R
    Scand J Rheumatol; 1984; 13(1):15-20. PubMed ID: 6609426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.
    Yamasaki Y; Narain S; Hernandez L; Barker T; Ikeda K; Segal MS; Richards HB; Chan EK; Reeves WH; Satoh M
    Arthritis Res Ther; 2006; 8(4):R111. PubMed ID: 16846524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
    Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
    Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ANA-specific antibodies, ANA patterns, anti-ds-DNA results, and clinical diagnosis: a laboratory and clinical audit.
    Anis S; Fatima A; Abdul Jabbar S; Arain T
    Immunol Res; 2023 Apr; 71(2):267-275. PubMed ID: 36456720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome.
    Juby A; Johnston C; Davis P; Russell AS
    Br J Rheumatol; 1992 Mar; 31(3):185-8. PubMed ID: 1540788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The incidence and clinical significance of antibodies to extractable nuclear antigens.
    Hamburger M; Hodes S; Barland P
    Am J Med Sci; 1977; 273(1):21-8. PubMed ID: 300568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High titers of antinuclear antibody and the presence of multiple autoantibodies are highly suggestive of systemic lupus erythematosus.
    Li H; Zheng Y; Chen L; Lin S
    Sci Rep; 2022 Feb; 12(1):1687. PubMed ID: 35105907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of combined antinuclear and anticytoplasmic antibodies detected by immunofluorescence.
    Lee TK; Rothberger H
    Chin Med J (Engl); 1989 Dec; 102(12):911-5. PubMed ID: 2517735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.